Hem › Icke-småcellig lungcancer › Florida › Deltona
Kliniska studier för Icke-småcellig lungcancer i Deltona, FL
15 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Deltona (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekryterarFas 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · 4 mi bort
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RekryterarFas 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · 4 mi bort
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- Alpha Clinical Research Centers LLC, Orange City · 4 mi bort
- Florida Cancer Specialists, Orange City · 4 mi bort
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi bort
- och 1 fler
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekryterarFas 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi bort
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RekryterarFas 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi bort
Pan-tumor MRD Study
RekryterarObservationsstudie
- Mid Florida Cancer Centers, Orange City · 4 mi bort
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekryterarFas 3
- Research Site, Orange City · 4 mi bort
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekryterarFas 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi bort
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekryterarFas 2/3
- Mid Florida Cancer Centers, Orange City · 4 mi bort
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
RekryterarFas 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi bort
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekryterarFas 2/3
- Local Institution - 007-926-B, Daytona Beach · 26 mi bort
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekryterarFas 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · 4 mi bort
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekryterarFas 3
- Research Site, Orange City · 4 mi bort
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekryterarFas 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi bort
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RekryterarFas 2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi bort
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Deltona
- Övervikt11 studier
- Alzheimers sjukdom10 studier
- Typ 2-diabetes10 studier
- Övervikt9 studier
- Bröstcancer8 studier
- Lungcancer8 studier
- Cancer (alla typer)7 studier
- Metastaserande cancer5 studier
- KOL5 studier
- Högt blodtryck5 studier
- Melanom5 studier
- Knäartros5 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.